Talk of possible Genzyme sale heating up
The Cambridge biotech company is being pursued by French drug company Sanofi-Aventis. WBZ New England Business Editor Anthony Silva talked with Ken Bredemeier, senior health care reporter at The Deal.

Watch CBS News
The Cambridge biotech company is being pursued by French drug company Sanofi-Aventis. WBZ New England Business Editor Anthony Silva talked with Ken Bredemeier, senior health care reporter at The Deal.
